Literature DB >> 2957953

Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography.

B Joos, R Lüthy.   

Abstract

An isocratic reversed-phase high-pressure liquid chromatographic method for the determination of six components of the teicoplanin complex in biological fluid was developed. By using fluorescence detection after precolumn derivatization with fluorescamine, the assay is specific and highly sensitive, with reproducibility studies yielding coefficients of variation ranging from 1.5 to 8.5% (at 5 to 80 micrograms/ml). Response was linear from 2.5 to 80 micrograms/ml (r = 0.999); the recovery from spiked human serum was 76%. An external quality control was performed to compare this high-pressure liquid chromatographic method (H) with a standard microbiological assay (M); no significant deviation from slope = 1 and intercept = 0 was found by regression analysis (H = 1.03M - 0.45; n = 15).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957953      PMCID: PMC174907          DOI: 10.1128/AAC.31.8.1222

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin.

Authors:  L Cavenaghi; A Corti; G Cassani
Journal:  J Hosp Infect       Date:  1986-03       Impact factor: 3.926

2.  Structure and conformation of epimers derived from the antibiotic teicoplanin.

Authors:  J C Barna; D H Williams; P Strazzolini; A Malabarba; T W Leung
Journal:  J Antibiot (Tokyo)       Date:  1984-10       Impact factor: 2.649

3.  Teicoplanin.

Authors:  A H Williams; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1984-11       Impact factor: 5.790

4.  In vitro activity and human pharmacokinetics of teicoplanin.

Authors:  L Verbist; B Tjandramaga; B Hendrickx; A Van Hecken; P Van Melle; R Verbesselt; J Verhaegen; P J De Schepper
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors:  F Parenti; G Beretta; M Berti; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

6.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.

Authors:  M R Bardone; M Paternoster; C Coronelli
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649

7.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).

Authors:  A Borghi; C Coronelli; L Faniuolo; G Allievi; R Pallanza; G G Gallo
Journal:  J Antibiot (Tokyo)       Date:  1984-06       Impact factor: 2.649

8.  In vitro activity of teichomycin compared with those of other antibiotics.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

9.  Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids.

Authors:  L Jadeja; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

10.  Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.

Authors:  R Pallanza; M Berti; B P Goldstein; E Mapelli; E Randisi; R Scotti; V Arioli
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

View more
  3 in total

Review 1.  Clinical pharmacokinetics of teicoplanin.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1990-03       Impact factor: 6.447

Review 2.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

3.  Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

Authors:  M J Rybak; E M Bailey; V N Reddy
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.